Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation

Cerebellar ataxias (CAs) are neurological diseases characterized by loss of muscle coordination that is a result of damage and inflammation to the cerebellum. Despite considerable efforts in basic and clinical research, most CAs are currently incurable. In this study, we evaluated the therapeutic po...

Full description

Bibliographic Details
Main Authors: Youngpyo Nam, Dongyeong Yoon, Jungwan Hong, Min Sung Kim, Tae Yong Lee, Kyung Suk Kim, Ho-Won Lee, Kyoungho Suk, Sang Ryong Kim
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/11/3654
_version_ 1797547974441566208
author Youngpyo Nam
Dongyeong Yoon
Jungwan Hong
Min Sung Kim
Tae Yong Lee
Kyung Suk Kim
Ho-Won Lee
Kyoungho Suk
Sang Ryong Kim
author_facet Youngpyo Nam
Dongyeong Yoon
Jungwan Hong
Min Sung Kim
Tae Yong Lee
Kyung Suk Kim
Ho-Won Lee
Kyoungho Suk
Sang Ryong Kim
author_sort Youngpyo Nam
collection DOAJ
description Cerebellar ataxias (CAs) are neurological diseases characterized by loss of muscle coordination that is a result of damage and inflammation to the cerebellum. Despite considerable efforts in basic and clinical research, most CAs are currently incurable. In this study, we evaluated the therapeutic potential of human mesenchymal stem cells (hMSCs) against CAs associated with neuroinflammation. We observed that hMSC treatment significantly inhibited the symptoms of ataxia in lipopolysaccharide (LPS)-induced inflammatory CA (ICA) mice, which were recently reported as a potential animal model of ICA, through the anti-inflammatory effect of hMSC-derived TNFα-stimulated gene-6 (TSG-6), the protection of Purkinje cells by inhibition of apoptosis, and the modulatory effect for microglial M2 polarization. Thus, our results suggest that hMSC treatment may be an effective therapeutic approach for preventing or improving ataxia symptoms.
first_indexed 2024-03-10T14:51:43Z
format Article
id doaj.art-51755b37d2bd4244b938ccfa5ff20625
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T14:51:43Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-51755b37d2bd4244b938ccfa5ff206252023-11-20T20:52:54ZengMDPI AGJournal of Clinical Medicine2077-03832020-11-01911365410.3390/jcm9113654Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with NeuroinflammationYoungpyo Nam0Dongyeong Yoon1Jungwan Hong2Min Sung Kim3Tae Yong Lee4Kyung Suk Kim5Ho-Won Lee6Kyoungho Suk7Sang Ryong Kim8Brain Science and Engineering Institute, Kyungpook National University, Daegu 41566, KoreaBK21 Plus KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, KoreaBrain Science and Engineering Institute, Kyungpook National University, Daegu 41566, KoreaBioengineering Institute, Corestem Inc., Seoul 13486, KoreaBioengineering Institute, Corestem Inc., Seoul 13486, KoreaBioengineering Institute, Corestem Inc., Seoul 13486, KoreaBrain Science and Engineering Institute, Kyungpook National University, Daegu 41566, KoreaBrain Science and Engineering Institute, Kyungpook National University, Daegu 41566, KoreaBrain Science and Engineering Institute, Kyungpook National University, Daegu 41566, KoreaCerebellar ataxias (CAs) are neurological diseases characterized by loss of muscle coordination that is a result of damage and inflammation to the cerebellum. Despite considerable efforts in basic and clinical research, most CAs are currently incurable. In this study, we evaluated the therapeutic potential of human mesenchymal stem cells (hMSCs) against CAs associated with neuroinflammation. We observed that hMSC treatment significantly inhibited the symptoms of ataxia in lipopolysaccharide (LPS)-induced inflammatory CA (ICA) mice, which were recently reported as a potential animal model of ICA, through the anti-inflammatory effect of hMSC-derived TNFα-stimulated gene-6 (TSG-6), the protection of Purkinje cells by inhibition of apoptosis, and the modulatory effect for microglial M2 polarization. Thus, our results suggest that hMSC treatment may be an effective therapeutic approach for preventing or improving ataxia symptoms.https://www.mdpi.com/2077-0383/9/11/3654cerebellar ataxianeuroinflammationmicrogliamesenchymal stem celllipopolysaccharide
spellingShingle Youngpyo Nam
Dongyeong Yoon
Jungwan Hong
Min Sung Kim
Tae Yong Lee
Kyung Suk Kim
Ho-Won Lee
Kyoungho Suk
Sang Ryong Kim
Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation
Journal of Clinical Medicine
cerebellar ataxia
neuroinflammation
microglia
mesenchymal stem cell
lipopolysaccharide
title Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation
title_full Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation
title_fullStr Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation
title_full_unstemmed Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation
title_short Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation
title_sort therapeutic effects of human mesenchymal stem cells in a mouse model of cerebellar ataxia with neuroinflammation
topic cerebellar ataxia
neuroinflammation
microglia
mesenchymal stem cell
lipopolysaccharide
url https://www.mdpi.com/2077-0383/9/11/3654
work_keys_str_mv AT youngpyonam therapeuticeffectsofhumanmesenchymalstemcellsinamousemodelofcerebellarataxiawithneuroinflammation
AT dongyeongyoon therapeuticeffectsofhumanmesenchymalstemcellsinamousemodelofcerebellarataxiawithneuroinflammation
AT jungwanhong therapeuticeffectsofhumanmesenchymalstemcellsinamousemodelofcerebellarataxiawithneuroinflammation
AT minsungkim therapeuticeffectsofhumanmesenchymalstemcellsinamousemodelofcerebellarataxiawithneuroinflammation
AT taeyonglee therapeuticeffectsofhumanmesenchymalstemcellsinamousemodelofcerebellarataxiawithneuroinflammation
AT kyungsukkim therapeuticeffectsofhumanmesenchymalstemcellsinamousemodelofcerebellarataxiawithneuroinflammation
AT howonlee therapeuticeffectsofhumanmesenchymalstemcellsinamousemodelofcerebellarataxiawithneuroinflammation
AT kyounghosuk therapeuticeffectsofhumanmesenchymalstemcellsinamousemodelofcerebellarataxiawithneuroinflammation
AT sangryongkim therapeuticeffectsofhumanmesenchymalstemcellsinamousemodelofcerebellarataxiawithneuroinflammation